Every day, over 300 million families across the globe wake up to another battle against rare diseases. There are over 7000 known rare diseases, with more being discovered all time. While these conditions may be individually rare (i.e. less than 1/200,000 people), when you put them together, having a rare disease is all too common. … Continue reading A disease may be rare, but finding answers should not be.
Category: Blog
CEO Reid Robison Discusses Tute Genomics with StartUp Health Now
CEO Reid Robison met with StartUp Health Now to discuss the founding and ongoing development and growth of Tute Genomics. Robison commented that, “One thing that I really like to emphasize is that, you’ve got to believe 100 percent in your idea or it’s not worth doing…Luckily, it’s a good time to be, not only … Continue reading CEO Reid Robison Discusses Tute Genomics with StartUp Health Now
Tute Genomics Welcomes New VP of Marketing Josh Forsythe
We have officially announced the tremendous addition of Josh Forsythe to our Tute team as Vice President of Marketing. We are thrilled to have such expertise and knowledge driving our marketing department. CEO, Reid Robison, shared his excitement about having Josh aboard saying, “Josh’s vast experience commercializing software technology in a highly complex and evolving … Continue reading Tute Genomics Welcomes New VP of Marketing Josh Forsythe
Tute Selected as Utah Innovation Award Recipient
We’re honored to have been selected for a Utah Innovation Award in the Life Science/BioTech category. Here’s some more information from Utah Business about our innovative technology: “Every human has about three billion base pairs in his or her DNA—far too much data to analyze with a simple Excel spreadsheet. That’s where Tute Genomics’ cloud-based genomic … Continue reading Tute Selected as Utah Innovation Award Recipient
Improve Diagnostic Rates, Speed Up Turnaround Times, Reduce Costs
You need fast, accurate answers to your most difficult-to-interpret genomic variants. We are here to help! Introducing ‘Expert Review’ by Tute Genomics, a new, supplementary service to our precision medicine platform that provides the necessary decision support to ensure you interpret variants faster and solve challenging cases sooner. Expert Review is a manual review of individual … Continue reading Improve Diagnostic Rates, Speed Up Turnaround Times, Reduce Costs
Exploring Genetic Variation with Google Genomics and Tute
Human genome sequencing is fast becoming standard practice for both clinicians and researchers now that the cost to read all 3 billion letters of a person’s DNA has dropped to just a few thousand dollars. But what does all that information mean for medicine and health? At Tute Genomics we’re answering that question by building … Continue reading Exploring Genetic Variation with Google Genomics and Tute
ACMG 2015 & Tute Genomics: Sign up for Free VCF Analysis!
The ACMG (The American College for Genetics and Genomics) annual conference is later this month in Salt Lake City, Utah. We will be there - will you? If you’re going, we have a challenge for you: We want you to bring your most challenging VCF file—that’s right, your very hardest one—to the Tute Genomics booth … Continue reading ACMG 2015 & Tute Genomics: Sign up for Free VCF Analysis!
Rare Disease Day 2015
Rare Disease Day is a worldwide day of recognition for the individuals that suffer with a recorded 7000 rare diseases. A “rare disease” is defined in the United States as a disease that affect fewer than 200,000 people at any one time, although standards vary by the country. Rare diseases, taken together, are estimated to affect 10% … Continue reading Rare Disease Day 2015
THE GENOME WAR (Round Two)
Venter versus Collins (again) and the Race for Precision Medicine in the Petabyte Era. The Precision Medicine Initiative announced by President Obama in 2015 State of the Union Address has created quite a stir, with the overall tone being one of optimism for the future of personalized medicine. The driving force behind this enormous undertaking … Continue reading THE GENOME WAR (Round Two)
CEO Dr. Reid Robison Speaks at SLAS2015 Conference
Last week, CEO Dr. Reid Robison spoke at the 2015 SLAS (Society for Lab Automation and Screening) conference. Held Feb. 7-11, 2015, the fourth annual SLAS Conference and Exhibition hosted 4,695 participants from 34 countries. Dr. Robison spoke about innovations in genome analysis, an Tute’s role in the future of precision medicine (including a special … Continue reading CEO Dr. Reid Robison Speaks at SLAS2015 Conference